影响射频消融治疗浅静脉反流后静脉性腿溃疡愈合与复发的因素
该回顾性研究纳入62条接受射频消融(RFA)治疗浅静脉反流的活动性或已愈合静脉性腿溃疡(VLU)患肢,评估愈合率、复发率及相关因素。结果显示,同期对病理性穿通静脉行超声引导泡沫硬化剂治疗(UGFS)与VLU愈合显著相关,而深静脉反流是VLU复发的唯一危险因素。
要点
- RFA后1年VLU愈合率为66%,3年复发率为23%。
- 同期UGFS处理病理性穿通静脉可改善VLU愈合(HR 2.84)。
- 深静脉反流患者VLU复发风险更高(HR 3.72),需加强监测。
核心结论
- RFA治疗浅静脉反流时同期行病理性穿通静脉UGFS可改善VLU愈合。
- 合并深静脉反流的患者VLU复发更频繁,建议监测溃疡复发。
研究设计与样本
- 回顾性研究,纳入2011年1月至2017年12月在泰国Siriraj医院接受RFA的活动性或已愈合VLU患者。
- 共62条患肢(活动性32条,已愈合30条),RFA靶血管包括大隐静脉(n=56)、副大隐静脉(n=5)或两者(n=1)。
- 采用Kaplan-Meier分析愈合时间和复发时间,Cox回归分析相关因素。
主要发现
- RFA后3个月、6个月、1年VLU愈合率分别为31%、56%、66%。
- RFA后1年、2年、3年VLU复发率分别为8%、14%、23%。
关键数值与推荐
- VLU愈合率:3个月31%,6个月56%,1年66%。
- VLU复发率:1年8%,2年14%,3年23%。
临床怎么用
- 对接受RFA的VLU患者,可考虑同期行病理性穿通静脉UGFS以改善愈合。
- 对合并深静脉反流的VLU患者,RFA后应加强溃疡复发监测。
局限性
- 回顾性研究设计。
- 样本量较小(62条患肢)。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovenous radiofrequency ablation (RFA) is one of the most popular techniques for correcting superficial vein reflux. However, the effectiveness of RFA of superficial vein reflux in patients with active or healed venous leg ulcer (VLU) is unknown. Accordingly, the objective of this study was to evaluate the healing rate, the recurrence rate, and the factors significantly associated with healing and recurrence in patients with active or healed VLU who had superficial venous reflux treated with RFA. METHODS: We retrospectively reviewed all healed VLU or active VLU patients treated with RFA at the Division of Vascular Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, during January 2011 to December 2017 to evaluate the rate of VLU healing and recurrence. Time to healing and time to ulcer recurrence were determined by Kaplan-Meier survival analysis. Risk factors were assessed to determine their association with VLU healing and recurrence by Cox regression survival analysis. RESULTS: RFA of the great saphenous vein (n = 56), anterior accessory saphenous vein (n = 5), or both (n = 1) was performed on 62 limbs with active (n = 32) or healed (n = 30) VLUs. The mean age of patients was 65.4 ± 9.8 years, and 80% were female. Deep venous insufficiency was present in 10 limbs (16%). Pathologic perforating vein was found in 17 patients (27%). Concomitant ultrasound-guided foam sclerotherapy (UGFS) of the pathologic perforating vein was performed in 12 limbs (19%). Concomitant phlebectomy was performed in 19 limbs (31%). The median follow-up time was 753 days after RFA. VLU healed in 31% of patients at 3 months, in 56% at 6 months, and in 66% at 1 year after RFA. Concomitant UGFS of the pathologic perforating vein was the only factor significantly associated with VLU healing (hazard ratio, 2.84; 95% confidence interval, 1.07-7.55; P = .037). VLU recurrence was found in 8% of patients at 1 year, in 14% at 2 years, and in 23% at 3 years after RFA. Deep vein reflux was the only identified risk factor for VLU recurrence (hazard ratio, 3.72; 95% confidence interval, 1.05-13.21; P = .042). CONCLUSIONS: UGFS of the pathologic perforating vein at the time of RFA of saphenous vein reflux improved VLU healing. VLU recurrence was more frequent in patients with concomitant deep vein reflux. The authors suggest performing UGFS of the pathologic perforating vein at the time of RFA to improve VLU healing and monitoring of patients with associated deep vein reflux for ulcer recurrence.
引用
- Sermsathanasawadi N, Jieamprasertbun J, Pruekprasert K, et al. Factors that influence venous leg ulcer healing and recurrence rate after endovenous radiofrequency ablation of incompetent saphenous vein. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31843485. doi:10.1016/j.jvsv.2019.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。